CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
GIMate +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04754724
NCT04754724N/ACompleted
CompareCT.gov

Evaluation of GIMate Handheld Hydrogen Breath Monitor for Diagnosis of Lactose Malabsorption

Vivante Health·interventional·Posted Feb 15, 2021·Updated Sep 28, 2021

In Brief

A clinical study evaluating GIMate and H2 Check for Lactose Intolerance. Completed, enrolled 31 participants across 1 site.

Detailed Summary

The goal of this study is to assess the performance of the Vivante Health GIMate Breathalyzer device in diagnosing lactose malabsorption.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLactose Intolerance
CountriesUnited States
CollaboratorsDuke University

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedFeb 15, 2021
Enrollment StartApr 1, 2021
Primary CompletionJul 15, 2021
Study CompletionAug 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 5.4 years ago

Interventions

GIMateother

Use of GIMate to detect lactose malabsorption

H2 Checkother

Use of H2 Check to detect lactose malabsorption